Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh

Tuesday, August 1, 2017

Please reTweet! Thank you!

Dr. Liv Tørres, Executive Director of the Nobel Peace Center in Oslo, Norway was the keynote speaker at #LWNC2017  Leadership Women National Conference in Dallas, TX July 29.  As a Leadership Women board member, I was privileged to meet and talk with her at length and share some information about this blog, my training as a 2010 FDA/CDRH Patient Representative, alliances with harmed patients and observations at state and Federal trials.  Patient safety is a global issue!

No comments:

Post a Comment